全文获取类型
收费全文 | 700篇 |
免费 | 66篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 31篇 |
妇产科学 | 22篇 |
基础医学 | 158篇 |
口腔科学 | 19篇 |
临床医学 | 80篇 |
内科学 | 114篇 |
皮肤病学 | 11篇 |
神经病学 | 76篇 |
特种医学 | 23篇 |
外科学 | 63篇 |
综合类 | 6篇 |
预防医学 | 64篇 |
眼科学 | 5篇 |
药学 | 55篇 |
肿瘤学 | 36篇 |
出版年
2024年 | 1篇 |
2023年 | 10篇 |
2022年 | 14篇 |
2021年 | 13篇 |
2020年 | 16篇 |
2019年 | 15篇 |
2018年 | 18篇 |
2017年 | 21篇 |
2016年 | 18篇 |
2015年 | 22篇 |
2014年 | 31篇 |
2013年 | 31篇 |
2012年 | 63篇 |
2011年 | 59篇 |
2010年 | 32篇 |
2009年 | 29篇 |
2008年 | 62篇 |
2007年 | 62篇 |
2006年 | 51篇 |
2005年 | 38篇 |
2004年 | 51篇 |
2003年 | 32篇 |
2002年 | 36篇 |
2001年 | 15篇 |
2000年 | 1篇 |
1999年 | 6篇 |
1998年 | 3篇 |
1996年 | 1篇 |
1994年 | 1篇 |
1992年 | 2篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1983年 | 1篇 |
1978年 | 1篇 |
1975年 | 2篇 |
1973年 | 1篇 |
1967年 | 1篇 |
排序方式: 共有770条查询结果,搜索用时 15 毫秒
11.
Warren Kati Gennadiy Koev Michelle Irvin Jill Beyer Yaya Liu Preethi Krishnan Thomas Reisch Rubina Mondal Rolf Wagner Akhteruzzaman Molla Clarence Maring Christine Collins 《Antimicrobial agents and chemotherapy》2015,59(3):1505-1511
Dasabuvir (ABT-333) is a nonnucleoside inhibitor of the RNA-dependent RNA polymerase encoded by the hepatitis C virus (HCV) NS5B gene. Dasabuvir inhibited recombinant NS5B polymerases derived from HCV genotype 1a and 1b clinical isolates, with 50% inhibitory concentration (IC50) values between 2.2 and 10.7 nM, and was at least 7,000-fold selective for the inhibition of HCV genotype 1 polymerases over human/mammalian polymerases. In the HCV subgenomic replicon system, dasabuvir inhibited genotype 1a (strain H77) and 1b (strain Con1) replicons with 50% effective concentration (EC50) values of 7.7 and 1.8 nM, respectively, with a 13-fold decrease in inhibitory activity in the presence of 40% human plasma. This level of activity was retained against a panel of chimeric subgenomic replicons that contained HCV NS5B genes from 22 genotype 1 clinical isolates from treatment-naive patients, with EC50s ranging between 0.15 and 8.57 nM. Maintenance of replicon-containing cells in medium containing dasabuvir at concentrations 10-fold or 100-fold greater than the EC50 resulted in selection of resistant replicon clones. Sequencing of the NS5B coding regions from these clones revealed the presence of variants, including C316Y, M414T, Y448C, Y448H, and S556G, that are consistent with binding to the palm I site of HCV polymerase. Consequently, dasabuvir retained full activity against replicons known to confer resistance to other polymerase inhibitors, including the S282T variant in the nucleoside binding site and the M423T, P495A, P495S, and V499A single variants in the thumb domain. The use of dasabuvir in combination with inhibitors targeting HCV NS3/NS4A protease (ABT-450 with ritonavir) and NS5A (ombitasvir) is in development for the treatment of HCV genotype 1 infections. 相似文献
12.
13.
Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia 总被引:3,自引:0,他引:3
BACKGROUND: Familial combined hyperlipidemia (FCHL) is the most common hereditary lipid disorder that predisposes the patients to premature coronary heart disease. Members of FCHL families are categorised as affected or unaffected according to serum lipid levels. This study is aimed to evaluate whether there is a difference in carotid artery wall thickness between asymptomatic FCHL family members who are affected and those who are unaffected according to the currently used lipid criteria. METHODS AND RESULTS: Carotid artery ultrasonography with intima-media thickness (IMT) measurements was performed for 148 members of 39 Finnish FCHL families. Study subjects who had no history of coronary heart disease or stroke were divided into two groups according to their serum total cholesterol and/or triglyceride levels. The average carotid IMT of the affected subjects (0.75+/-0.15 mm) was not significantly different from that of their unaffected relatives (0.73+/-0.13 mm), P=0.90. In multivariate analysis, age, gender, and pulse pressure, but no lipid variables, contributed significantly to the variation of carotid IMT. CONCLUSIONS: The IMT findings in FCHL family members indicate that the current lipid criteria alone are of limited value in predicting long-term risk of cardiovascular disease in asymptomatic members of FCHL families. 相似文献
14.
15.
16.
Audrey Anna Bolyard Merideth L. Kelley Jennifer E. Below Michael J. Bamshad Kathryn M. Bofferding Joshua D. Smith Kati Buckingham Laurence A. Boxer Julia Skokowa Karl Welte Deborah A. Nickerson Gail P. Jarvik David C. Dale for the UW Center for Mendelian Genomics 《Human mutation》2014,35(7):824-827
Severe congenital neutropenia (SCN) is a rare hematopoietic disorder, with estimated incidence of 1 in 200,000 individuals of European descent, many cases of which are inherited in an autosomal dominant pattern. Despite the fact that several causal genes have been identified, the genetic basis for >30% of cases remains unknown. We report a five‐generation family segregating a novel single nucleotide variant (SNV) in TCIRG1. There is perfect cosegregation of the SNV with congenital neutropenia in this family; all 11 affected, but none of the unaffected, individuals carry this novel SNV. Western blot analysis show reduced levels of TCIRG1 protein in affected individuals, compared to healthy controls. Two unrelated patients with SCN, identified by independent investigators, are heterozygous for different, rare, highly conserved, coding variants in TCIRG1. 相似文献
17.
18.
Li Z Huang H Li Y Jiang X Chen P Arnovitz S Radmacher MD Maharry K Elkahloun A Yang X He C He M Zhang Z Dohner K Neilly MB Price C Lussier YA Zhang Y Larson RA Le Beau MM Caligiuri MA Bullinger L Valk PJ Delwel R Lowenberg B Liu PP Marcucci G Bloomfield CD Rowley JD Chen J 《Blood》2012,119(10):2314-2324
Increased expression levels of miR-181 family members have been shown to be associated with favorable outcome in patients with cytogenetically normal acute myeloid leukemia. Here we show that increased expression of miR-181a and miR-181b is also significantly (P < .05; Cox regression) associated with favorable overall survival in cytogenetically abnormal AML (CA-AML) patients. We further show that up-regulation of a gene signature composed of 4 potential miR-181 targets (including HOXA7, HOXA9, HOXA11, and PBX3), associated with down-regulation of miR-181 family members, is an independent predictor of adverse overall survival on multivariable testing in analysis of 183 CA-AML patients. The independent prognostic impact of this 4-homeobox-gene signature was confirmed in a validation set of 271 CA-AML patients. Furthermore, our in vitro and in vivo studies indicated that ectopic expression of miR-181b significantly promoted apoptosis and inhibited viability/proliferation of leukemic cells and delayed leukemogenesis; such effects could be reversed by forced expression of PBX3. Thus, the up-regulation of the 4 homeobox genes resulting from the down-regulation of miR-181 family members probably contribute to the poor prognosis of patients with nonfavorable CA-AML. Restoring expression of miR-181b and/or targeting the HOXA/PBX3 pathways may provide new strategies to improve survival substantially. 相似文献
19.
20.
Thorsten Suess Cornelius Remschmidt Susanne B Schink Brunhilde Schweiger Andreas Nitsche Kati Schroeder Joerg Doellinger Jeanette Milde Walter Haas Irina Koehler Gérard Krause Udo Buchholz 《BMC infectious diseases》2012,12(1):1-16